Sabby Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$8.3 - $16.8 $267,177 - $540,792	-32,190 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.1 - $16.0 $136,161 - $268,960	-16,810 Reduced 34.31%	32,190 $317,000
Q4 2017 Feb 14, 2018	SELL	$10.5 - $14.15 $456,750 - $615,525	-43,500 Reduced 47.03%	49,000 $684,000
Q3 2017 Nov 14, 2017	BUY	$7.7 - $11.55 $712,250 - $1.07 Million	92,500	92,500 $1.02 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.